MetaCap

Odyssey Therapeutics Statistics

NASDAQ: ODTXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

16.96-1.38 (-7.52%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Odyssey Therapeutics by the numbers

Odyssey Therapeutics has a market capitalization of $815.2 million based on 48.07M shares outstanding. With trailing EPS of $-6.33, Odyssey Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 14.9% below its 50-day average and 13.8% below its 200-day average.

Average daily trading volume is 329.31K shares, or about $5.6 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

ODTX valuation vs. peer median

ODTX compared with the median of 8 peer companies
MetricODTXPeer medianDifference
Market cap$815.23M$759.09M+7%
Avg. volume329.31K904.98K-64%

Peer median across 8 companies: BBTX, PRME, MGTX, IMTX, GLUE, AURA, SLDB, ATTO.

Valuation

Price and trading

Previous close
18.34
Open
17.65
Day range
16.46 – 18.08
52-week range
15.10 – 29.05
Beta
—
Volume
677.84K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
815.23M
Forward Pe
-3.82
Eps
-6.33
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
29.05
Week52 Low
15.10
Avg Volume
329.31K
Shares Outstanding
48.07M
Ma50
19.93
Ma200
19.68
Earnings Date
Nov 4, 2026
Pct From52w High
-41.62%
Pct From52w Low
12.32%

Related